CAFFEINE SELF-ADMINISTRATION, WITHDRAWAL, AND ADVERSE-EFFECTS AMONG COFFEE DRINKERS

被引:1
作者
HUGHES, JR
HIGGINS, ST
BICKEL, WK
HUNT, WK
FENWICK, JW
GULLIVER, SB
MIREAULT, GC
机构
[1] UNIV VERMONT, DEPT PSYCHOL, BURLINGTON, VT 05401 USA
[2] UNIV VERMONT, DEPT MED BIOSTAT, BURLINGTON, VT 05401 USA
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Twenty-two coffee drinkers (three to seven cups per day) underwent repeated double-blind trials to test for caffeine self-administration, withdrawal, and adverse effects. Each trial consisted first of a randomized crossover period of 1 day of decaffeinated coffee and 1 day of caffeinated coffee (100 mg) to assess withdrawal and adverse effects of caffeine. Next, subjects were given 2 days of concurrent access to the two coffees. The relative use of the two coffees was used to assess caffeine self-administration. Reliable caffeine self-administration occurred in three of 10 subjects in study 1 and seven of 12 subjects in study 2. Withdrawal symptoms were headaches, drowsiness, and fatigue. The major adverse effect from self-administration was tremulousness. The occurrence of headaches on substitution of decaffeinated coffee prospectively predicted subsequent self-administration of caffeine. These results indicate that some coffee drinkers exhibit signs of a caffeine dependence, ie, they self-administer coffee for the effects of caffeine, have withdrawal symptoms on cessation, and experience adverse effects.
引用
收藏
页码:611 / 617
页数:7
相关论文
共 32 条
[1]  
American Psychiatric Association, 1987, DIAGNOSTIC STAT MANU, V3rd
[2]  
Amerine M., 1965, PRINCIPLES SENSORY E
[3]  
Cappell H., 1981, RES ADV ALCOHOL DRUG, V6, P159
[4]   EFFECTS OF CAFFEINE ON CIGARETTE-SMOKING AND SUBJECTIVE RESPONSE [J].
CHAIT, LD ;
GRIFFITHS, RR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (05) :612-622
[5]  
Dreisbach RH, 1943, J LAB CLIN MED, V28, P1212
[6]  
EVANS S, 1988, NIDA RES MONOGRAPH, V90
[7]   POSSIBLE PSYCHIATRIC SIGNIFICANCE OF EXCESSIVE COFFEE CONSUMPTION [J].
FURLONG, FW .
CANADIAN PSYCHIATRIC ASSOCIATION JOURNAL, 1975, 20 (08) :577-583
[8]  
Gilbert R. M., 1976, RES ADV ALCOHOL DRUG, P49
[9]  
GILLILAND K, 1984, ADDICT BEHAV, P53
[10]  
GOLDSTEIN A, 1969, CLIN PHARMACOL THER, V10, P477